v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
REVENUE $ 15,998,239 $ 13,790,294
Cost of Revenue 3,049,441 3,225,803
GROSS PROFIT 12,948,798 10,564,491
EXPENSES    
Selling, general and administrative expenses 8,493,365 10,857,797
Research and development expenses 2,764,197 2,155,660
TOTAL OPERATING EXPENSES 11,257,562 13,013,457
INCOME (LOSS) FROM OPERATIONS 1,691,236 (2,448,966)
Other income/(expense) [Note 3] 159,978 (78,569)
Interest expense (3,361,950) (3,262,038)
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] 19,842 (137,934)
Accretion and amortization expenses (745,896) (1,939,816)
Change in fair value of derivative liabilities [Note 8] (167,349) (553,856)
NET LOSS BEFORE INCOME TAXES (2,404,139) (8,421,179)
Income taxes
NET LOSS BEFORE DIVIDENDS (2,404,139) (8,421,179)
Preferred Stock Dividends (724,319) (466,141)
Deemed Dividend (3,054,680)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS (3,128,458) (11,942,000)
Translation adjustment (35,547) 113,414
COMPREHENSIVE LOSS $ (3,164,005) $ (11,828,586)
LOSS PER SHARE, BASIC $ (0.115) $ (0.555)
LOSS PER SHARE, DILUTED $ (0.115) $ (0.555)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC 27,304,317 21,524,884
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED 27,304,317 21,524,884